bnn also know spiroandrostenoxiranol synthet neurosteroid microneurotrophin analogu endogen neurosteroid dehydroepiandrosteron dhea act select highaffin central activ agonist trka trkb pntr receptor neurotrophin nerv growth factor ngf brainder neurotroph factor bdnf well dhea dhea sulfat dhea drug suggest potenti novel treatment parkinson diseas condit surpris discoveri make dhea well dhea direct bind activ trka pntr high affin dhea subsequ also find bind trkb trkc high affin though notabl activ trkc trkb dhea dhea bind receptor affin low nanomolar rang around nm although affin nonetheless approxim two order magnitud low relat high potent polypeptid neurotrophin nm case dhea dhea identifi import endogen neurotroph factor find may explain posit associ decreas circul dhea level age agerel neurodegen diseas subsequ seri spiro deriv dhea synthes assess potenti neuroprotect agent reinvestig bnn assay find direct bind activ trka trkb pntr addit find cross bloodbrain barrier strong neuroprotect effect dopaminerg neuron vivo mous model dopaminerg neurodegener depend least part activ trkb moreov unlik dhea lack hormon action bnn describ bdnf mimet propos potenti novel treatment parkinson diseas condit particular neurodegen varieti like amyotroph later sclerosi